Lead Gilead researcher highlights need for inclusive clinical trials for HIV
A lead researcher from Gilead’s flagship human immunodeficiency virus (HIV) PURPOSE programme has highlighted the importance of sponsors better considering trial design when recognising and addressing global health inequalities. Ahead of World AIDS day on …